This article explains the current status of GLP-1 patch development, proper administration techniques for approved injectable formulations, and what patients should know about transdermal medication delivery principles if such products become available in the future
Food and Drug Administration (FDA) hasnt approved any weight loss patches that work like the blockbuster injected GLP-1 drugs Ozempic, Wegovy, Zepbound, and Mounjaro, says Jody Dushay, MD, an assistant professor at Harvard Medical School and an endocrinologist at Beth Israel Deaconess Medical Center in Boston
In clinical trials, people lost an average of 17% of their body weight over 64 weeks, with around one in four losing 20% or more
Your health is far too important to risk on unproven products
In contrast, Kind Patches sells non-prescription supplement patches without medical oversight or proven results
Social media influencers are touting a new option for popular weight loss drugs: GLP-1 patches, they say, are just as powerful as Ozempic for shedding pounds without the discomfort of needles or the hassle of getting a prescription
